Mohammad Reza Shanesaz, the head of Food and Drug Administration of the Islamic Republic of Iran (FDA) announced on Friday that three local companies are ready to produce the antiviral drug Favipiravir, which is said to be effective in the treatment of COVID-19, Mehr News Agency reported.
Related News:
- US benchmark WTI oil price closes at -$37.63/barrel
- Iran rejects Trump’s interference wrapped in coronavrius aid offer
- Dozens dead in fresh wave of Taliban violence in Afghanistan
- India sends medical aid to Iran amid coronavirus pandemic
- Rouhani: There is no way to ensure regional security but cooperation
